-
1دورية أكاديمية
المؤلفون: Elena Kutumova, Anna Kovaleva, Ruslan Sharipov, Galina Lifshits, Fedor Kolpakov
المصدر: Heliyon, Vol 10, Iss 9, Pp e29988- (2024)
مصطلحات موضوعية: Mathematical modelling, ACE I/D polymorphism, Antihypertensive therapy, Cardiovascular system, Renal system, Blood pressure regulation, Science (General), Q1-390, Social sciences (General), H1-99
وصف الملف: electronic resource
العلاقة: http://www.sciencedirect.com/science/article/pii/S2405844024060195Test; https://doaj.org/toc/2405-8440Test
-
2دورية أكاديمية
المؤلفون: Laith Naser AL-Eitan, Saif Zuhair Alahmad
المصدر: Journal of Biosafety and Biosecurity, Vol 5, Iss 3, Pp 89-95 (2023)
مصطلحات موضوعية: ACE I/D Polymorphism, Arabs, COVID-19, Gender, SARS-CoV-2, Biology (General), QH301-705.5
وصف الملف: electronic resource
العلاقة: http://www.sciencedirect.com/science/article/pii/S2588933823000377Test; https://doaj.org/toc/2588-9338Test
-
3دورية أكاديمية
المؤلفون: Seyielenuo Suokhrie, Vineet Chaudhary, Sumit Mishra, Benrithung Murry, Naorem Kiranmala Devi
المصدر: Egyptian Journal of Medical Human Genetics, Vol 24, Iss 1, Pp 1-8 (2023)
مصطلحات موضوعية: ACE I/D polymorphism, Hypertension, Obesity, Cardiometabolic risk factors, Apolipoprotein, Young adults, Medicine (General), R5-920, Genetics, QH426-470
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/2090-2441Test
-
4دورية أكاديمية
المؤلفون: K.G. Starkova
المصدر: Analiz Riska Zdorovʹû, Iss 3, Pp 169-175 (2022)
مصطلحات موضوعية: essential hypertension, angiotensin converting enzyme, ace i/d polymorphism, dyslipidemia, pro-inflammatory cytokines, Medicine
وصف الملف: electronic resource
العلاقة: https://journal.fcrisk.ru/eng/2022/3/16Test; https://doaj.org/toc/2308-1155Test; https://doaj.org/toc/2308-1163Test
-
5دورية أكاديمية
المؤلفون: A. Moqadami, E. M. Agah, M. Khalaj-Kondori
المصدر: Siberian journal of oncology; Том 22, № 2 (2023); 85-92 ; Сибирский онкологический журнал; Том 22, № 2 (2023); 85-92 ; 2312-3168 ; 1814-4861
مصطلحات موضوعية: gap-ПЦР, ACE I/D polymorphism, glioblastoma, gap-PCR, полиморфизм АПФ I/D, глиобластома
وصف الملف: application/pdf
العلاقة: https://www.siboncoj.ru/jour/article/view/2536/1098Test; Louis D.N., Ohgaki H., Wiestler O.D., Cavenee W.K., Burger P.C., Jouvet A., Scheithauer B.W., Kleihues P. The 2007 WHO classifcation of tumours of the central nervous system. Acta Neuropathol. 2007; 114(2): 97–109. doi:10.1007/s00401-007-0243-4. Erratum in: Acta Neuropathol. 2007; 114(5): 547.; Tan A.C., Ashley D.M., López G.Y., Malinzak M., Friedman H.S., Khasraw M. Management of glioblastoma: State of the art and future directions. CA Cancer J Clin. 2020; 70(4): 299–312. doi:10.3322/caac.21613.; Rock K., McArdle O., Forde P., Dunne M., Fitzpatrick D., O’Neill B., Faul C. A clinical review of treatment outcomes in glioblastoma multiforme--the validation in a non-trial population of the results of a randomised Phase III clinical trial: has a more radical approach improved survival? Br J Radiol. 2012; 85(1017): 729–33. doi:10.1259/bjr/83796755.; Ohgaki H., Kleihues P. Genetic pathways to primary and secondary glioblastoma. Am J Pathol. 2007; 170(5): 1445–53. doi:10.2353/ajpath.2007.070011.; Ostrom Q.T., Patil N., Cioff G., Waite K., Kruchko C., Barnholtz-Sloan J.S. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017. Neuro Oncol. 2020; 22(12 Suppl 2): 1–96. doi:10.1093/neuonc/noaa200. Erratum in: Neuro Oncol. 2022; 24(7): 1214.; Thakkar J.P., Dolecek T.A., Horbinski C., Ostrom Q.T., Lightner D.D., Barnholtz-Sloan J.S., Villano J.L. Epidemiologic and molecular prognostic review of glioblastoma. Cancer Epidemiol Biomarkers Prev. 2014; 23(10): 1985–96. doi:10.1158/1055-9965.EPI-14-0275.; Ohka F., Natsume A., Wakabayashi T. Current trends in targeted therapies for glioblastoma multiforme. Neurol Res Int. 2012. doi:10.1155/2012/878425.; O’Rawe M., Kilmister E.J., Mantamadiotis T., Kaye A.H., Tan S.T., Wickremesekera A.C. The rennin-angiotensin system in the tumor microenvironment of glioblastoma. Cancers. 2021; 13(16): 4004. doi:10.3390/cancers13164004.; Nakagawa P., Gomez J., Grobe J.L., Sigmund C.D. The renin-angiotensin system in the central nervous system and its role in blood pressure regulation. Current hypertension reports. 2020; 22(1): 1–10.; Jackson L., Eldahshan W., Fagan S.C., Ergul A. Within the Brain: The Renin Angiotensin System. Int J Mol Sci. 2018; 19(3): 876. doi:10.3390/ijms19030876.; Labandeira-Garcia J.L., Rodríguez-Perez A.I., GarridoGil P., Rodriguez-Pallares J., Lanciego J.L., Guerra M.J. Brain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration. Front Aging Neurosci. 2017; 9: 129. doi:10.3389/fnagi.2017.00129.; Xu Q., Jensen D.D., Peng H., Feng Y. The critical role of the central nervous system (pro)renin receptor in regulating systemic blood pressure. Pharmacol Ther. 2016; 164: 126–34. doi:10.1016/j.pharmthera.2016.04.006.; Riquier-Brison A.D.M., Sipos A., Prókai Á., Vargas S.L., Toma L., Meer E.J., Villanueva K.G., Chen J.C.M., Gyarmati G., Yih C., Tang E., Nadim B., Pendekanti S., Garrelds I.M., Nguyen G., Danser A.H.J., Peti-Peterdi J. The macula densa prorenin receptor is essential in renin release and blood p ressure control. Am J Physiol Renal Physiol. 2018; 315(3): 521–34. doi:10.1152/ajprenal.00029.2018.; Bodiga V.L., Bodiga S. Renin angiotensin system in cognitive function and dementia. Asian J Neurosci. 2013. Article ID 102602. doi:10.1155/2013/102602.; Hamming I., Timens W., Bulthuis M.L., Lely A.T., Navis G., van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A frst step in understanding SARS pathogenesis. J Pathol. 2004; 203(2): 631–7. doi:10.1002/path.1570.; Cui C., Xu P., Li G., Qiao Y., Han W., Geng C., Liao D., Yang M., Chen D., Jiang P. Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: Role of renin-angiotensin system. Redox Biol. 2019; 26. doi:10.1016/j.redox.2019.101295.; Balyasnikova I.V., Metzger R., Sun Z.L., Berestetskaya Y.V., Albrecht R.F., Danilov S.M. Development and characterization of rat monoclonal antibodies to denatured mouse angiotensinconverting enzyme. Tissue Antigens. 2005; 65(3): 240–51. doi:10.1111/j.1399-0039.2005.00364.x.; Nakagawa P., Sigmund C.D. How Is the Brain ReninAngiotensin System Regulated? Hypertension. 2017; 70(1): 10–8. doi:10.1161/HYPERTENSIONAHA.117.08550.; Ziaja M., Urbanek K.A., Kowalska K., PiastowskaCiesielska A.W. Angiotensin II and Angiotensin Receptors 1 and 2-Multifunctional System in Cells Biology, What Do We Know? Cells. 2021; 10(2): 381. doi:10.3390/cells10020381.; Bradshaw A.R., Wickremesekera A.C., Brasch H.D., Chibnall A.M., Davis P.F., Tan S.T., Itinteang T. Glioblastoma Multiforme Cancer Stem Cells Express Components of the ReninAngiotensin System. Front Surg. 2016; 3: 51. doi:10.3389/fsurg.2016.00051.; Kouchi M., Shibayama Y., Ogawa D., Miyake K., Nishiyama A., Tamiya T. (Pro)renin receptor is crucial for glioma development via the Wnt/β-catenin signaling pathway. J Neurosurg. 2017; 127(4): 819–28. doi:10.3171/2016.9.JNS16431.; Hicks B.M., Filion K.B., Yin H., Sakr L., Udell J.A., Azoulay L. Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study. BMJ. 2018; 363. doi:10.1136/bmj.k4209.; Moghimi M., Kargar S., Jafari M.A., Ahrar H., Jarahzadeh M.H., Neamatzadeh H., Sadeghizadeh-Yazdi J. Angi- otensin Converting Enzyme Insertion/Deletion Polymorphism is Associated with Breast Cancer Risk: A Meta-Analysis. Asian Pac J Cancer Prev. 2018; 19(11): 3225–31. doi:10.31557/APJCP.2018.19.11.3225.; Wang Z.Y., Li H.Y., Jiang Z.P., Zhou T.B. Relationship between angiotensin-converting enzyme insertion/deletion gene polymorphism and prostate cancer susceptibility. J Cancer Res Ther. 2018; 14(S): 375–80. doi:10.4103/0973-1482.171366.; Pabalan N., Jarjanazi H., Ozcelik H. Associations of the Insertion/Deletion Polymorphism in the ACE Gene and Risk of Gastric Cancer: A Meta-Analysis. J Gastrointest Cancer. 2015; 46(4): 370–9. doi:10.1007/s12029-015-9754-8.; Röcken C., Lendeckel U., Dierkes J., Westphal S., CarlMcGrath S., Peters B., Krüger S., Malfertheiner P., Roessner A., Ebert M.P. The number of lymph node metastases in gastric cancer correlates with the angiotensin I-converting enzyme gene insertion/ deletion polymorphism. Clin Cancer Res. 2005; 11(7): 2526–30. doi:10.1158/1078-0432.CCR-04-1922.; Vairaktaris E., Yapijakis C., Tsigris C., Vassiliou S., Derka S., Nkenke E., Spyridonidou S., Vylliotis A., Vorris E., Ragos V., Neukam F.W., Patsouris E. Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with increased risk for oral cancer. Acta Oncol. 2007; 46(8): 1097–102. doi:10.1080/02841860701373579.; Kitsios G., Zintzaras E. ACE (I/D) polymorphism and response to treatment in coronary artery disease: a comprehensive database and meta-analysis involving study quality evaluation. BMC Med Genet. 2009; 10: 50. doi:10.1186/1471-2350-10-50.; Haiman C.A., Henderson S.O., Bretsky P., Kolonel L.N., Henderson B.E. Genetic variation in angiotensin I-converting enzyme (ACE) and breast cancer risk: the multiethnic cohort. Cancer Res. 2003; 63(20): 6984–7.; Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990; 86(4): 1343–6. doi:10.1172/JCI114844.; Jeunemaitre X. Genetics of the human renin angiotensin system. J Mol Med (Berl). 2008; 86(6): 637–41. doi:10.1007/s00109-008-0344-0.; Suehiro T., Morita T., Inoue M., Kumon Y., Ikeda Y., Hashi- moto K. Increased amount of the angiotensin-converting enzyme (ACE) mRNA originating from the ACE allele with deletion. Hum Genet. 2004; 115(2): 91–6. doi:10.1007/s00439-004-1136-4.; Holland E.C. Glioblastoma multiforme: the termina- tor. Proceedings of the National Academy of Sciences of the United States of America. 2000; 97(12): 6242–4. doi:10.1073/pnas.97.12.6242.; Maher E.A., Furnari F.B., Bachoo R.M., Rowitch D.H., Louis D.N., Cavenee W.K., DePinho R.A. Malignant glioma: genetics and biology of a grave matter. Genes Dev. 2001; 15(11): 1311–33. doi:10.1101/gad.891601.; Schwartzbaum J.A., Fisher J.L., Aldape K.D., Wrensch M. Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol. 2006; 2(9): 494–503. doi:10.1038/ncpneuro0289.; Agnihotri S., Burrell K.E., Wolf A., Jalali S., Hawkins C., Rutka J.T., Zadeh G. Glioblastoma, a brief review of history, molecular genetics, animal models and novel therapeutic strategies. Arch Immunol Ther Exp (Warsz). 2013; 61(1): 25–41. doi:10.1007/s00005-012-0203-0.; Ostrom Q.T., Gittleman H., Truitt G., Boscia A., Kruchko C., Barnholtz-Sloan J.S. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015. Neuro Oncol. 2018; 20(s4):1–86. doi:10.1093/neuonc/noy131. Erratum in: Neuro Oncol. 2018.; Lian M., Jiang H., Wang H., Guo S. Angiotensinconverting enzyme insertion/deletion gene polymorphisms is associated with risk of glioma in a Chinese population. J Renin Angiotensin Aldosterone Syst. 2015; 16(2): 443–7. doi:10.1177/1470320313495910.; Pandith A.A., Qasim I., Zahoor W., Shah P., Bhat A.R. ACE I/D sequence variants but not MTHFR C677T, is strongly linked to malignant glioma risk and its variant DD genotype may act as a promising predictive biomarker for overall survival of glioma patients. Gene. 2018; 639: 62–8. doi:10.1016/j.gene.2017.10.013.; Benenemissi I.H., Sifi K., Sahli L.K., Semmam O., Abadi N., Satta D. Angiotensin-converting enzyme insertion/ deletion gene polymorphisms and the risk of glioma in an Algerian population. Pan Afr Med J. 2019; 32: 197. doi:10.11604/pamj.2019.32.197.15129.; Sun M., Fang Y., Ma S., Gao X., Sun Y. The genetic polymorphisms of angiotensin converting enzyme insertion/deletion and glioma susceptibility: A meta-analysis. J Renin Angiotensin Al- dosterone Syst. 2020; 21(4). doi:10.1177/1470320320963939.; https://www.siboncoj.ru/jour/article/view/2536Test
الإتاحة: https://doi.org/10.21294/1814-4861-2023-22-2-85-92Test
https://doi.org/10.1007/s00401-007-0243-4Test
https://doi.org/10.3322/caac.21613Test
https://doi.org/10.2353/ajpath.2007.070011Test
https://doi.org/10.1093/neuonc/noaa200Test
https://doi.org/10.1158/1055-9965.EPI-14-0275Test
https://doi.org/10.1155/2012/878425Test
https://doi.org/10.3390/cancers13164004Test
https://doi.org/10.3390/ijms19030876Test
https://doi.org/10.3389/fnagi.2017.00129Test -
6دورية أكاديمية
المؤلفون: Alves, Silvia Marinho Martins, Alvarado-Arnês, Lúcia Elena, Cavalcanti, Maria da Glória Aureliano de Melo, Carrazzone, Cristina de Fátima Velloso, Pacheco, Antônio Guilherme Fonseca, Sarteschi, Camila, Moraes, Milton Ozorio, Oliveira Junior, Wilson Alves de, Medeiros, Carolina de Araújo, Pessoa, Fernanda Gallinaro, Mady, Charles, Lannes-Vieira, Joseli, Ramires, Felix José Alvarez
المصدر: Revista da Sociedade Brasileira de Medicina Tropical. January 2020 53
مصطلحات موضوعية: Chagas disease, ACE I/D polymorphism, Cardiomyopathy, Heart failure
وصف الملف: text/html
-
7دورية أكاديمية
المؤلفون: Silvia Marinho Martins Alves, Lúcia Elena Alvarado-Arnês, Maria da Glória Aureliano de Melo Cavalcanti, Cristina de Fátima Velloso Carrazzone, Antônio Guilherme Fonseca Pacheco, Camila Sarteschi, Milton Ozorio Moraes, Wilson Alves de Oliveira Junior, Carolina de Araújo Medeiros, Fernanda Gallinaro Pessoa, Charles Mady, Joseli Lannes-Vieira, Felix José Alvarez Ramires
المصدر: Revista da Sociedade Brasileira de Medicina Tropical, Vol 53 (2020)
مصطلحات موضوعية: Chagas disease, ACE I/D polymorphism, Cardiomyopathy, Heart failure, Arctic medicine. Tropical medicine, RC955-962
وصف الملف: electronic resource
العلاقة: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822020000100329&tlng=enTest; https://doaj.org/toc/1678-9849Test
-
8دورية أكاديمية
المؤلفون: Umme Najiya Mahwish, Kamakshi Chaithri Ponnaluri, Babi Heera, Satish Reddy Alavala, K Rudrama Devi, Sree Bhushan Raju, G Suman Latha, Parveen Jahan
المصدر: Indian Journal of Nephrology, Vol 30, Iss 2, Pp 77-84 (2020)
مصطلحات موضوعية: ace i/d polymorphism, diabetic nephropathy, dyslipidemia, type 2 diabetes, Diseases of the genitourinary system. Urology, RC870-923
العلاقة: http://www.indianjnephrol.org/article.asp?issn=0971-4065;year=2020;volume=30;issue=2;spage=77;epage=84;aulast=MahwishTest; https://doaj.org/toc/0971-4065Test; https://doaj.org/toc/1998-3662Test; https://doaj.org/article/3319ab5dc2e147fa8f0f7a6ae3e1ed00Test
الإتاحة: https://doi.org/10.4103/ijn.IJN_244_18Test
https://doaj.org/article/3319ab5dc2e147fa8f0f7a6ae3e1ed00Test -
9دورية أكاديمية
المؤلفون: Selvaraman Nagamani, M. Shanmuga Perumal, R. Leela Shanmuga Perumal, Chandrasekhar Kesavan, Kartikeyan Muthusamy
المصدر: Egyptian Journal of Medical Human Genetics, Vol 16, Iss 1, Pp 29-33 (2015)
مصطلحات موضوعية: Case control study, ACE I/D polymorphism, Chronic Kidney Disease, HWE, Medicine (General), R5-920, Genetics, QH426-470
وصف الملف: electronic resource
العلاقة: http://www.sciencedirect.com/science/article/pii/S1110863014001190Test; https://doaj.org/toc/1110-8630Test
-
10دورية أكاديمية
المؤلفون: Omayma M. Hassanin, Maha Moustafa, Tarek M. El Masry
المصدر: Egyptian Journal of Medical Human Genetics, Vol 15, Iss 4, Pp 355-360 (2014)
مصطلحات موضوعية: ACE I/D polymorphism, Alzheimer’s disease, Plasma ACE, Medicine (General), R5-920, Genetics, QH426-470
وصف الملف: electronic resource
العلاقة: http://www.sciencedirect.com/science/article/pii/S1110863014000640Test; https://doaj.org/toc/1110-8630Test